Akademik Veri Yönetim Sistemi
AIN SHAMS JOURNAL OF ANESTHESIOLOGY, cilt.14, sa.76, ss.1-18, 2022 (ESCI)
Background: Achieving adequate pain control during and after the uterine D/C (dilatation and curettage) procedure is crucial for a good recovery process and early discharge. The study was conducted to find out whether intravenous dexketoprofen trometamol is more effective than tramadol and paracetamol in easing pain during the D/C procedure as well as to assess its effectiveness in the recovery period. Results: Significant differences were determined between the groups regarding the values of Ramsey sedation scores (p=0.048). VAS (visual analog scale) mean values of group T were higher compared to the VAS mean values of group D (p=0.02). A significant difference was found between group P and group D (p=0.016), the mean VAS values of group P were higher than group D. Conclusions: We found out that preemptive intravenous 25 mg dexketoprofen trometamol administered in the daily D/C procedure provides good quality postoperative analgesia with minimal adverse effects by reducing the need for rescue analgesia, and is more effective in postoperative analgesia than paracetamol and tramadol.